Your browser doesn't support javascript.
loading
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Tanriover, Mine Durusu; Doganay, Hamdi Levent; Akova, Murat; Güner, Hatice Rahmet; Azap, Alpay; Akhan, Sila; Köse, Sükran; Erdinç, Fatma Sebnem; Akalin, Emin Halis; Tabak, Ömer Fehmi; Pullukçu, Hüsnü; Batum, Özgür; Simsek Yavuz, Serap; Turhan, Özge; Yildirmak, Mustafa Taner; Köksal, Iftihar; Tasova, Yesim; Korten, Volkan; Yilmaz, Gürdal; Çelen, Mustafa Kemal; Altin, Sedat; Çelik, Ilhami; Bayindir, Yasar; Karaoglan, Ilkay; Yilmaz, Aydin; Özkul, Aykut; Gür, Hazal; Unal, Serhat.
Affiliation
  • Tanriover MD; Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
  • Doganay HL; Department of Gastroenterology, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Istanbul, Turkey.
  • Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey. Electronic address: makova@hacettepe.edu.tr.
  • Güner HR; Department of Infectious Diseases and Clinical Microbiology, Ankara Yildirim Beyazit University, Ankara City Hospital, Ankara, Turkey.
  • Azap A; Department of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.
  • Akhan S; Department of Infectious Diseases and Clinical Microbiology, Kocaeli University School of Medicine, Kocaeli, Turkey.
  • Köse S; Department of Infectious Diseases, Turkish Republic Ministry of Health, Izmir Provincial Health Directorate, Izmir University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.
  • Erdinç FS; Department of Infectious Diseases, Turkish Republic Ministry of Health, Ankara Provincial Health Directorate, Ankara Training and Research Hospital, Ankara, Turkey.
  • Akalin EH; Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University Health Application and Research Centre, Bursa Uludag University Hospital, Bursa, Turkey.
  • Tabak ÖF; Department of Infectious Diseases and Clinical Microbiology, Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Pullukçu H; Department of Infectious Diseases and Clinical Microbiology, Ege University School of Medicine, Izmir, Turkey.
  • Batum Ö; Department of Chest Diseases, Turkish Republic Ministry of Health, Izmir Provincial Health Directorate, University of Health Sciences Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey.
  • Simsek Yavuz S; Department of Infectious Diseases and Clinical Microbiology, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey.
  • Turhan Ö; Department of Infectious Diseases and Clinical Microbiology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Yildirmak MT; Department of Infectious Diseases and Clinical Microbiology, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, Prof Dr Cemil Tascioglu City Hospital, Istanbul, Turkey.
  • Köksal I; Department of Infectious Diseases and Clinical Microbiology, Acibadem University Atakent Hospital, Istanbul, Turkey.
  • Tasova Y; Department of Infectious Diseases and Clinical Microbiology, Çukurova University Balcali Hospital Health Application and Research Centre, Adana, Turkey.
  • Korten V; Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey.
  • Yilmaz G; Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey; Department of Chest Diseases, Turkish Republic Ministry of Health, Ankara Provincial Health Directorate, Ankara Keçiören Sanatorium, Atatürk Chest Diseases and Thoracic Su
  • Çelen MK; Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.
  • Altin S; Department of Chest Diseases, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, University of Health Sciences Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
  • Çelik I; Department of Infectious Diseases and Clinical Microbiology, Turkish Republic Ministry of Health, Kayseri City Training and Research Hospital, Kayseri, Turkey.
  • Bayindir Y; Department of Infectious Diseases and Clinical Microbiology, Inönü University Turgut Özal Health Centre, Malatya, Turkey.
  • Karaoglan I; Department of Infectious Diseases and Clinical Microbiology, Gaziantep University Sahinbey Research and Application Centre, Gaziantep, Turkey.
  • Yilmaz A; Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey; Department of Chest Diseases, Turkish Republic Ministry of Health, Ankara Provincial Health Directorate, Ankara Keçiören Sanatorium, Atatürk Chest Diseases and Thoracic Su
  • Özkul A; Department of Virology, Ankara University Faculty of Veterinary Medicine, Ankara, Turkey.
  • Gür H; Department of Medical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey.
  • Unal S; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
Lancet ; 398(10296): 213-222, 2021 07 17.
Article in En | MEDLINE | ID: mdl-34246358
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Guideline Limits: Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Clinical_trials / Guideline Limits: Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Year: 2021 Document type: Article Affiliation country: Country of publication: